drugset / Trial / NCT00835185
Study of IMC-11F8 in Participants With Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if IMC-11F8 in combination with chemotherapy is effective in treating colorectal cancer (CRC).
Timeline
- Start
- 2007-08
- Primary completion
- 2010-01
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Necitumumab | Monoclonal antibody | 800 mg | Intravenous |
| Background | Leucovorin | Small molecule | 400 mg/m2 | Intravenous |
| Background | Oxaliplatin | Small molecule | 85 mg/m2 | Intravenous |
| Background | fluorouracil | Small molecule | 2400 mg/m2 | Intravenous |